Skip to main navigation
ArriVent Biopharma logo
  • Overview
  • News & Events
    • News Releases
    • Events & Presentations
  • Corporate Governance
    • Governance Documents
    • Executive Team
    • Board of Directors
    • Committee Composition
  • Financial Information
    • SEC Filings
    • Quarterly Results
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • IR Resources
    • Investor FAQs
    • Email Alerts
    • Investor Contact
ArriVent Biopharma image

SEC Filing Details

Financial Information
  • SEC Filings

Document Details

Form
8-K
Filing Date
Mar 17, 2026
Document Date
Mar 17, 2026
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
ArriVent Biopharma
Issuer
ARRIVENT BIOPHARMA, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - EX-101.LAB
EX-101.PRE - EX-101.PRE
XML - XBRL INSTANCE DOCUMENT
drafts jallaire@lifesciadvisors.com
©2026 ArriVent Biopharma, Inc. All rights reserved.
ARRIVENT and  Reg. U.S. Pat. & Tm. Off.
Search Investors